[VIEW] agent=Derivatives Market Risk Lead | scenario_id=18 | rounds=20

--- Round 0 ---
[R0.1] Collateral Operations Lead (speak, public): To ensure we're on the same page, let's start by reviewing the current state of our cleared margin operations. We're currently handling an average of 84 margin calls per day with a 97% same-day settlement rate. With the proposed expansion, we're expecting to add 2 new CCP relationships and see a 35% increase in margin call volume, taking it to 113 calls per day. Can you both confirm if these numbers align with your expectations and if there are any concerns regarding margin volatility?
[R0.2] Derivatives Market Risk Lead (speak, public): The numbers you've provided for the increase in margin call volume seem reasonable given our current portfolio composition and the proposed expansion. However, I'd like to understand more about the operational timing and processing constraints. Specifically, how do you plan to handle the 35% increase in margin calls without compromising our current 97% same-day settlement rate?
[R0.3] Finance & Treasury Business Partner (speak, public): From a liquidity and funding perspective, I'm concerned about the potential impact of increased margin calls on our cash collateral requirements. Can you provide more insight into the expected margin call frequency and the mechanics of how collateral will be mobilized, especially under stressed market conditions?

--- Round 1 ---
[R1.1] Collateral Operations Lead (speak, public): To address the increased margin call volume, we plan to maintain our current operational efficiency by optimizing our existing processes and potentially leveraging technology to streamline margin call processing. We're also reviewing our collateral inventory to ensure we have sufficient eligible assets. Currently, we have $1,800,000,000 in cash and $2,600,000,000 in UST (2–5Y) available for posting. Regarding stressed market conditions, I'd like to understand from you, Derivatives Market Risk Lead, if there are any specific stress scenarios we should be preparing for in terms of margin call frequency and collateral requirements.
[R1.2] Derivatives Market Risk Lead (speak, public): To better understand the stress scenarios, let's examine the potential impact of significant market movements on our initial margin requirements. For instance, a +100 bp parallel shift in interest rates could increase our initial margin by approximately $520,000,000. We should also consider the composition of our cleared portfolio, which is currently 62% IRS notional, 28% CDS notional, and 10% FX swaps notional. This information can help us gauge the potential margin call frequency and volume under stressed conditions. Additionally, I'd like to know more about the eligible assets available for collateral transformation and their associated costs.
[R1.3] Finance & Treasury Business Partner (speak, public): To better assess the liquidity impact, can you clarify how the $1,800,000,000 in cash and $2,600,000,000 in UST (2–5Y) will be utilized for margin calls, and what portion of these assets are readily available for collateral transformation without incurring significant costs or haircuts?

--- Round 2 ---
[R2.1] Collateral Operations Lead (speak, public): To address the utilization of our collateral inventory for margin calls, we currently have a minimum transfer amount of $250,000 and a standard call frequency of once per day. Our eligible collateral mix includes $1,800,000,000 in cash and $2,600,000,000 in UST (2–5Y), which are available for posting. The cash component can be readily used for margin calls without transformation, while the UST (2–5Y) may require some mobilization efforts but are generally considered high-quality liquid assets. Regarding collateral transformation costs, I'd like to hear from Finance & Treasury Business Partner about any constraints or costs associated with mobilizing these assets, especially under stressed market conditions.
[R2.2] Derivatives Market Risk Lead (speak, public): To better assess the risks associated with the expanded central-clearing and collateral-transformation operating model, I'd like to share some insights on our initial margin forecast for the next 30 days. We're expecting an average initial margin of $3,400,000,000, with a 95th percentile of $4,100,000,000. Given this context, can you provide more details on the costs associated with mobilizing our UST (2–5Y) securities for collateral transformation, especially under stressed market conditions?
[R2.3] Finance & Treasury Business Partner (speak, public): To address the costs associated with mobilizing our UST (2–5Y) securities for collateral transformation, we have a repo/collateral transformation capacity of up to $2,000,000,000 with a UST haircut of 2.5%. Our current funding cost assumptions are Secured O/N at SOFR + 12 bp and 3M term at SOFR + 28 bp. Under stressed market conditions, these costs could fluctuate, but we have a robust framework in place to manage these risks. Additionally, our recent average P&L carry on cash collateral has been negative, earning 4.6% on cash while paying 5.1% to the CCP. I believe these details are crucial for understanding the liquidity and funding implications of our expanded central-clearing and collateral-transformation operating model.

--- Round 3 ---
[R3.1] Collateral Operations Lead (speak, public): To summarize, we're expecting a 35% increase in margin call volume due to the expanded central-clearing model, and we've discussed various factors that could impact our operational readiness and funding costs. Derivatives Market Risk Lead, you've provided valuable insights into potential margin volatility under stressed market conditions, highlighting a possible increase in initial margin requirements. Finance & Treasury Business Partner, you've shared details on the costs associated with collateral transformation and funding. To finalize our assessment, I'd like to confirm that we've considered all critical aspects. Derivatives Market Risk Lead, are there any hidden tail risks or additional stress scenarios we should be aware of that could significantly impact our margin requirements or operational capacity? Finance & Treasury Business Partner, are there any internal treasury constraints or additional funding costs we should factor into our decision-making process?
[R3.2] Derivatives Market Risk Lead (speak, public): To address the question regarding hidden tail risks or additional stress scenarios, I believe it's crucial to consider the potential impact of significant market movements on our initial margin requirements, as previously discussed. Additionally, we should factor in the concentration and wrong-way risk associated with our cleared portfolio, although I can share general considerations around this topic, specific details remain sensitive. Finance & Treasury Business Partner, regarding internal treasury constraints or additional funding costs, have you considered the potential impact of liquidity floors or internal transfer pricing on our overall funding costs?
[R3.3] Finance & Treasury Business Partner (speak, public): To address the question regarding internal treasury constraints or additional funding costs, we're currently operating within our liquidity policy guidelines, with an internal LCR target of 110% and a current LCR of 117%. We also have a contingent liquidity buffer floor that requires maintaining $3,200,000,000 in unencumbered HQLA. While I can share that our internal transfer pricing mechanisms are in place, the specifics of these are sensitive. However, I can confirm that we've considered the impact of our funding cost assumptions and collateral transformation capacity on our overall funding costs. It's also worth noting that our recent average P&L carry on cash collateral has been negative, which is a factor in our overall cost assessment.

--- Round 4 ---
[R4.1] Collateral Operations Lead (speak, public): To summarize our discussion, we've assessed the operational feasibility and financial implications of the expanded central-clearing and collateral-transformation operating model. We've considered the expected increase in margin call volume, potential margin volatility under stressed market conditions, and the costs associated with collateral transformation and funding. Derivatives Market Risk Lead has highlighted the importance of considering concentration and wrong-way risk, while Finance & Treasury Business Partner has provided insights into our liquidity policy guidelines and internal LCR target. Given the information shared, I believe we have a comprehensive view to make an informed decision. I'd like to propose that we approve the expanded model, with the condition that we continue to monitor margin volatility and adjust our operational processes as necessary to maintain our settlement efficiency and manage funding costs effectively. I'd appreciate your feedback on this proposal.
[R4.2] Derivatives Market Risk Lead (speak, public): I support the proposal to approve the expanded central-clearing and collateral-transformation operating model, with the condition that we continue to monitor margin volatility and adjust our operational processes as necessary. It's crucial that we maintain our settlement efficiency and manage funding costs effectively. I've considered the potential risks, including margin volatility under stressed market conditions, and believe our current risk management framework is adequate. However, I recommend that we continue to review and update our risk management practices to address any emerging risks.
[R4.3] Finance & Treasury Business Partner (speak, public): I support the proposal to approve the expanded central-clearing and collateral-transformation operating model, with the condition that we continue to monitor margin volatility and adjust our operational processes as necessary. Our liquidity policy guidelines and funding cost assumptions have been considered, and we're confident in our ability to manage the associated risks. I recommend we move forward with the expansion while maintaining close oversight of our liquidity and funding costs.

--- Round 5 ---
[R5.1] Collateral Operations Lead (speak, public): I appreciate the support from both of you for the proposal to approve the expanded central-clearing and collateral-transformation operating model. Given our discussion and the conditions we've outlined, I believe we're ready to move forward. I'll summarize our key findings and recommendations in a final report for our stakeholders. Thank you for your insights and collaboration throughout this process.
[R5.2] Derivatives Market Risk Lead (leave, public): 
[R5.3] Finance & Treasury Business Partner (leave, public): 

--- Round 6 ---
[R6.1] Collateral Operations Lead (leave, public): 
[R6.2] Derivatives Market Risk Lead (leave, public): 
[R6.3] Finance & Treasury Business Partner (leave, public): 

--- Round 7 ---
[R7.1] Collateral Operations Lead (leave, public): 
[R7.2] Derivatives Market Risk Lead (leave, public): 
[R7.3] Finance & Treasury Business Partner (leave, public): 

--- Round 8 ---
[R8.1] Collateral Operations Lead (leave, public): 
[R8.2] Derivatives Market Risk Lead (leave, public): 
[R8.3] Finance & Treasury Business Partner (leave, public): 

--- Round 9 ---
[R9.1] Collateral Operations Lead (leave, public): 
[R9.2] Derivatives Market Risk Lead (leave, public): 
[R9.3] Finance & Treasury Business Partner (leave, public): 

--- Round 10 ---
[R10.1] Collateral Operations Lead (leave, public): 
[R10.2] Derivatives Market Risk Lead (leave, public): 
[R10.3] Finance & Treasury Business Partner (leave, public): 

--- Round 11 ---
[R11.1] Collateral Operations Lead (leave, public): 
[R11.2] Derivatives Market Risk Lead (leave, public): 
[R11.3] Finance & Treasury Business Partner (leave, public): 

--- Round 12 ---
[R12.1] Collateral Operations Lead (leave, public): 
[R12.2] Derivatives Market Risk Lead (leave, public): 
[R12.3] Finance & Treasury Business Partner (leave, public): 

--- Round 13 ---
[R13.1] Collateral Operations Lead (leave, public): 
[R13.2] Derivatives Market Risk Lead (leave, public): 
[R13.3] Finance & Treasury Business Partner (leave, public): 

--- Round 14 ---
[R14.1] Collateral Operations Lead (leave, public): 
[R14.2] Derivatives Market Risk Lead (leave, public): 
[R14.3] Finance & Treasury Business Partner (leave, public): 

--- Round 15 ---
[R15.1] Collateral Operations Lead (leave, public): 
[R15.2] Derivatives Market Risk Lead (leave, public): 
[R15.3] Finance & Treasury Business Partner (leave, public): 

--- Round 16 ---
[R16.1] Collateral Operations Lead (leave, public): 
[R16.2] Derivatives Market Risk Lead (leave, public): 
[R16.3] Finance & Treasury Business Partner (leave, public): 

--- Round 17 ---
[R17.1] Collateral Operations Lead (leave, public): 
[R17.2] Derivatives Market Risk Lead (leave, public): 
[R17.3] Finance & Treasury Business Partner (leave, public): 

--- Round 18 ---
[R18.1] Collateral Operations Lead (leave, public): 
[R18.2] Derivatives Market Risk Lead (leave, public): 
[R18.3] Finance & Treasury Business Partner (leave, public): 

--- Round 19 ---
[R19.1] Collateral Operations Lead (leave, public): 
[R19.2] Derivatives Market Risk Lead (leave, public): 
[R19.3] Finance & Treasury Business Partner (leave, public): 

